130 related articles for article (PubMed ID: 15726312)
1. [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].
Paiss T; Kahn D; Küfer R; Maier C; Vogel W; Gschwend JE; Hautmann RE; Herkommer K
Urologe A; 2005 Apr; 44(4):387-92. PubMed ID: 15726312
[TBL] [Abstract][Full Text] [Related]
2. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
[TBL] [Abstract][Full Text] [Related]
3. [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].
Herkommer K; Paiss T; Merz M; Gschwend JE; Kron M
Urologe A; 2006 Dec; 45(12):1532-9. PubMed ID: 17004091
[TBL] [Abstract][Full Text] [Related]
4. Genetic counseling for prostate cancer risk.
Nieder AM; Taneja SS; Zeegers MP; Ostrer H
Clin Genet; 2003 Mar; 63(3):169-76. PubMed ID: 12694223
[TBL] [Abstract][Full Text] [Related]
5. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
[TBL] [Abstract][Full Text] [Related]
6. [Preventing prostate carcinoma in men with familial disposition].
Paiss T; Gschwend JE; Maier C; Eisele M; Vogel W; Hautmann RE; Herkommer K
Urologe A; 2002 Nov; 41(6):596-601. PubMed ID: 12524947
[TBL] [Abstract][Full Text] [Related]
7. Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy.
Paiss T; Herkommer K; Bock B; Heinz H; Vogel W; Kron M; Kuefer R; Hautmann RE; Gschwend JE
Eur Urol; 2003 Jun; 43(6):615-21. PubMed ID: 12767361
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients.
Vadaparampil ST; Jacobsen PB; Kash K; Watson IS; Saloup R; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):753-8. PubMed ID: 15159306
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
10. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
Peters CA; Stock RG; Blacksburg SR; Stone NN
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
[TBL] [Abstract][Full Text] [Related]
11. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families.
Bock CH; Peyser PA; Montie JE; Cooney KA
Prostate; 2005 Jun; 64(1):60-6. PubMed ID: 15651090
[TBL] [Abstract][Full Text] [Related]
12. [Familial prostate cancer and genetic predisposition].
Meissner VH; Jahnen M; Herkommer K
Urologe A; 2021 May; 60(5):567-575. PubMed ID: 33721089
[TBL] [Abstract][Full Text] [Related]
13. Why do men refuse prostate cancer screening? Demographic analysis in Turkey.
Ceber E; Cakir D; Ogce F; Simsir A; Cal C; Ozentürk G
Asian Pac J Cancer Prev; 2008; 9(3):387-90. PubMed ID: 18990007
[TBL] [Abstract][Full Text] [Related]
14. Family history and prostate cancer screening with prostate-specific antigen.
Mäkinen T; Tammela TL; Stenman UH; Määttänen L; Rannikko S; Aro J; Juusela H; Hakama M; Auvinen A
J Clin Oncol; 2002 Jun; 20(11):2658-63. PubMed ID: 12039927
[TBL] [Abstract][Full Text] [Related]
15. Compliance with biopsy recommendations of a prostate cancer risk calculator.
van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
[TBL] [Abstract][Full Text] [Related]
17. Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.
Roumier X; Azzouzi R; Valéri A; Guillemin F; Fournier G; Cussenot O; Mangin P; Cormier L
Eur Urol; 2004 Mar; 45(3):280-5; author reply 285-6. PubMed ID: 15036671
[TBL] [Abstract][Full Text] [Related]
18. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
Cormier L; Valéri A; Azzouzi R; Fournier G; Cussenot O; Berthon P; Guillemin F; Mangin P
Prostate; 2002 Jun; 51(4):276-85. PubMed ID: 11987156
[TBL] [Abstract][Full Text] [Related]
19. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
Mayer M; Selig K; Tüttelmann F; Dinkel A; Gschwend JE; Herkommer K
Fam Cancer; 2019 Apr; 18(2):221-230. PubMed ID: 30229510
[TBL] [Abstract][Full Text] [Related]
20. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
